Historical record - last NADAC effective date: 1/1/2021

Product Information

CHANTIX 0.5 MG TABLET is a brand product labeled by Pfizer Inc., priced at $7.8518 per EA under NDC 00069046856. Its NADAC has been published 425 times since Nov 28, 2013.

FDA first approved this application on May 10, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the varenicline tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CHANTIX 0.5 MG TABLET

varenicline tartrate
$7.8518per EA
High Outlier

Strength

.5 mg/1

Manufacturer

Pfizer Inc.

NDC

00069046856

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

1/1/2021

Active Ingredients

VARENICLINE TARTRATE

Approval Type

New Drug (NDA)

FDA Application

NDA021928

FDA Approved

5/10/2006

TE Code

AB

On Market Since

5/10/2006

Pharmacological Classes

Cholinergic Agonists
Cholinergic Receptor Agonist
Partial Cholinergic Nicotinic Agonist
Partial Cholinergic Nicotinic Agonists

Price Statistics

The NADAC for CHANTIX 0.5 MG TABLET has been published 425 times since Nov 28, 2013, and over the history we have for it it has risen 128.8%. The table below summarizes its recorded NADAC range and movement.

Current price$7.8518 per EA
All-time high$7.8518 (Jan 12, 2022)
All-time low$3.4324 (Nov 28, 2013)
Median price$6.2592
Average price$6.1315
Largest weekly change+9.4% (Jan 10, 2018)
Weeks tracked425
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

0.0%

All

+128.8%

Last surveyed Jan 12, 2022 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CHANTIX 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CHANTIX 0.5 MG TABLET, manufactured by Pfizer Inc., is $7.8518 per EA (NDC 00069046856), effective Jan 12, 2022.

How has the price of CHANTIX 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CHANTIX 0.5 MG TABLET has risen 128.8%. It has been tracked across 425 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CHANTIX 0.5 MG TABLET?

Since Nov 28, 2013, the NADAC for CHANTIX 0.5 MG TABLET has ranged from a low of $3.4324 (Nov 28, 2013) to a high of $7.8518 (Jan 12, 2022), with a median of $6.2592 per EA.

Are there cheaper alternatives to CHANTIX 0.5 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VARENICLINE 0.5 MG TABLET, is $0.3364 per EA — about 96% below CHANTIX 0.5 MG TABLET.

Who manufactures CHANTIX 0.5 MG TABLET?

CHANTIX 0.5 MG TABLET (NDC 00069046856) is labeled by Pfizer Inc., and CMS classifies it as a brand product.